HIGHLIGHTS
- who: Efstathios S. Giotis et al. from the Department of Infectious Diseases, Imperial College London, London , PG, UK School of Life Sciences, University of Essex, Colchester , SQ, UK have published the research work: Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients, in the Journal: Viruses 2022, 14, 2728. of /2022/
- future: Building on results from former clinical trials future trials should focus on antiandrogens or ADT in combinatorial therapeutic modalities against COVID-19. And Further Perspectives Considering the prohibiting cost of current COVID-19 drug regimens for low- and middle-income countries the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.